Challenges for medicinal chemistry

Drug Discovery Today

Volumn 1, Issue 12, 1996, Pages 529-532

  Wess, Günther ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003095407     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(96)10047-7     Document Type: Review

References (13)

1. Burger, A. (1994) Med. Chem. Res. 4, 3-15
2. Kornberg, A. (1989) Perspect. Biochemistry 1, 1-4
3. Triggle, D.J. (1993) Annu. Rep. Med. Chem. 28, 343-350
4. Beam, A. (1991) Nature 353, 873
5. deStevens, G. (1991) J. Med. Chem. 34, 2665-2670
6. Drews, J. (1995) The Impact of Cost Containment on Pharmaceutical Research and Development, 10th CMR Annual Lecture
7. Wurtman, R.J. and Bettiker, R.L. (1995) Nat. Med. 1, 1122-1125
8. Pharma Pipelines, New Timelines for the Pharmaceutical Industry (January 1996), Lehmann Brothers
9. Scrip Magazine (1996) July/August, 50-52
10. Ganellin, C.R., Mitscher, L.A. and Topliss, I.G. ( 1995) Annu. Rep. Med. Chem. 30, 329-338
11. Caporale, L.H. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 75-82
12. Eschenmoser, A. (1994) Angew. Chem. 106, 2455
13. Kornberg, A. (1995) The Golden Helix, University Science Books